MARY COLBERG: Open Payments
NPI 1578902110 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 18 payments from 8 companies in 2025. Trend: 2023 $1,978 · 2024 $840 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $94 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Alkermes, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| ABBVIE INC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: INGREZZA, SPRAVATO, COBENFY, ARISTADA, VRAYLAR, Auvelity, REXULTI, VIVITROL.
Industry payments across NJ — which companies pay providers there.
